Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation.

NCT01066689 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT01066689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01066689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation.
Lead sponsor
University Hospital, Tours
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2008
Completion date
October 31, 2011
Enrollment
64 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

graft rejection